BioPoly LLC Expands Intellectual Property Portfolio with Newly Granted U.S. Patent for Shoulder Implant

FORT WAYNE, IN – BioPoly LLC continues to strengthen its leadership in orthopedic innovation with the issuance of U.S. Patent No. 12,208,013 by the U.S. Patent and Trademark Office. This latest patent protects the BioPoly® Hill-Sachs Implant, a breakthrough solution designed to stabilize the shoulder joint in patients experiencing chronic dislocations while preserving the integrity of opposing cartilage.

With a robust intellectual property portfolio of more than two dozen patents, BioPoly safeguards its proprietary designs, manufacturing methods, and materials. The company’s patented BioPoly® synthetic cartilage material—a unique combination of ultrahigh molecular weight polyethylene (UHMWPE) and hyaluronic acid—is engineered to mimic the function of natural cartilage, offering a cutting-edge approach to joint restoration.

BioPoly’s material technology has been successfully applied across a growing portfolio of orthopedic implants, including:

· FDA-cleared implants: Great Toe, Lesser Toe, and Radial Head

· FDA-approved clinical trial implant: Knee

· Prior CE-marked implants: Knee, Patella, Trochlear Groove, and Shoulder

As BioPoly continues to advance its orthopedic solutions, the company remains committed to developing next-generation implants that address painful joint conditions caused by cartilage damage. ISO 13485 certified and headquartered in Fort Wayne, Indiana, BioPoly is at the forefront of orthopedic innovation.